KB Financial Partners’s Bio-Techne TECH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-876
Closed -$73K – 605
2022
Q4
$73K Buy
876
+168
+24% +$13.3K 0.02% 234
2022
Q3
$50K Sell
708
-108
-13% -$9.33K 0.02% 244
2022
Q2
$71K Sell
816
-12
-1% -$1.13K 0.02% 230
2022
Q1
$90K Buy
828
+68
+9% +$7.02K 0.02% 228
2021
Q4
$98K Buy
+760
New +$93.2K 0.03% 235
2021
Q3
– Sell
-368
Closed -$41K – 524
2021
Q2
$41K Sell
368
-80
-18% -$8.42K 0.02% 279
2021
Q1
$43K Buy
+448
New +$40.9K 0.02% 281

Other funds holding TECH

KB Financial Partners's TECH Position: Q1 2023 in Review

KB Financial Partners sold out of Bio-Techne (TECH) in Q1 2023, closing a stake of 876 shares — an estimated $73K sold.

KB Financial Partners first reported a position in TECH in Q1 2021 and held it in 7 quarters. The position peaked at $98K in Q4 2021. 550 funds tracked by Wall St. Rank hold TECH as of Q1 2023.

  • KB Financial Partners reported no remaining Bio-Techne position as of Q1 2023 after selling out during the quarter.
  • KB Financial Partners sold 876 Bio-Techne shares in Q1 2023, an estimated $73K.
  • KB Financial Partners first reported a position in Bio-Techne in Q1 2021 and held it in 7 quarters.
  • KB Financial Partners's Bio-Techne position peaked at $98K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2023.

Based on KB Financial Partners's 13F filing for Q1 2023, filed 17 May 2023.